VolitionRx Signs Non-Binding LOI to Develop NETosis Test
VolitionRx signed a non-binding LOI with Missionpharma to explore development, manufacturing support and distribution of a prototype lateral flow test for NETosis, including potential decentralized use in LMICs and neonatal sepsis triage.